Cell Saver Use in Bilateral Total Hip Arthroplasty (THA)

NCT01468129 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2011-11-09

No results posted yet for this study

Summary

This study will investigate the efficacy of using cell saver during bilater total hip arthroplasty

Conditions

  • One-stage Bilateral Total Hip Replacement

Interventions

OTHER

Cell Saver

Sponsors & Collaborators

  • Rothman Institute Orthopaedics

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01468129 on ClinicalTrials.gov